[1]吕翠岩,郑爽,贾晓蕾,等.参芪地黄汤化裁方对早期糖尿病肾病患者血糖及尿蛋白的影响[J].西部中医药,2021,34(09):51-53.[doi:10.12174/j.issn.2096-9600.2021.09.14]
　LYU Cuiyan,ZHENG Shuang,JIA Xiaolei,et al.Effects of Modified Prescription of Shenqi Dihuang Decoction on Blood Glucose and Urinary Protein in Early Diabetic Kidney Disease[J].Western Journal of Traditional Chinese Medicine,2021,34(09):51-53.[doi:10.12174/j.issn.2096-9600.2021.09.14]
点击复制

参芪地黄汤化裁方对早期糖尿病肾病患者血糖及尿蛋白的影响
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
34
期数:
2021年09期
页码:
51-53
栏目:
博士论坛
出版日期:
2021-09-15

文章信息/Info

Title:
Effects of Modified Prescription of Shenqi Dihuang Decoction on Blood Glucose and Urinary Protein in Early Diabetic Kidney Disease
作者:
吕翠岩1, 郑爽2, 贾晓蕾3, 张岩4, 刘铜华5
1.首都医科大学附属北京中医医院肾内科，北京 100010
2.北京中医药大学研究生院
3.北京中医药大学附属第三医院
4.首都医科大学附属北京友谊医院中医科
5.北京中医药大学
Author(s):
LYU Cuiyan1, ZHENG Shuang2, JIA Xiaolei3, ZHANG Yan4, LIU Tonghua5
1.Department of Nephrology, Beijing Hospital of TCM Affiliated to Capital Medical University, Beijing 100010, China
2.Graduate School, Beijing University of Chinese Medicine
3.Beijing University of Chinese Medicine, Third Affiliated Hospital
关键词:
糖尿病肾病; 早期; 气阴两虚夹瘀; 血糖; 证候积分; 尿蛋白肌酐比值
Keywords:
diabetic kidney disease;  early; and deficiency intermingled with stasis; blood glucose; syndrome integrals; UACR
分类号:
R245
DOI:
10.12174/j.issn.2096-9600.2021.09.14
摘要:
目的探讨参芪地黄汤化裁方对早期糖尿病肾病（diabetic kidney disease，DKD）患者血糖及尿蛋白的影响。 方法40例气阴两虚夹瘀型早期DKD（DKD Ⅲ期）患者在西医治疗基础上，予参芪地黄汤化裁方汤剂口服，连服12周，观察临床疗效及治疗前后患者中医证候积分、空腹血糖（fasting blood glucose，FBG）、餐后2 h血糖（2-hour postprandial blood glucose，2hPG）、糖化血红蛋白（glycosylated hemoglobin，HbA1c）、肌酐（serum creatinine，SCr）、尿素氮（blood urea nitrogen，BUN）、尿白蛋白肌酐比值（UACR）变化情况。 结果与治疗前比较，治疗后患者中医证候积分下降（P＜0.01），UACR、FBG、2hPG和HbA1c水平降低（P＜0.01），SCr、BUN水平变化不明显（P＞0.05）；临床总有效率为87.50%。 结论参芪地黄汤化裁方联合西药能改善早期DKD气阴亏虚、脉络瘀阻证患者的临床症状，降低血糖、UACR水平及减少血糖和UACR对肾脏的损害，控制早期DKD进展，保护肾功能。
Abstract:
ObjectiveTo discuss the effects of modified prescription of Shenqi Dihuang decoction on blood glucose and urinary protein in early diabetic kidney disease (DKD). MethodsForty patients suffering DKD at stage Ⅲ of Qi and Yin deficiency intermingled with stasis took modified Shenqi Dihuang decoction orally for 12 weeks consecutively on the foundation of Western medicine therapy, to observe clinical effects, TCM syndrome integrals, FBG, 2hPG, HbA1c, SCr, BUN, UACR before and after treating. ResultsCompared with before treating, TCM syndrome integrals lowered after treating (P<0.01), the levels of UACR, FBG, 2hPG and HbA1c lowered (P<0.01), the levels of SCr and BUN changed insignificantly (P>0.05); clinical total effective rate was 87.50%. ConclusionModified Shenqi Dihuang decoction joined with Western medicine could improve clinical symptoms in patients with early DKD of Qi and Yin deficiency intermingled with stasis pattern, lower the levels of blood glucose, the levels of UACR, the damage of blood glucose and UACR to kidney, control the progress of early DKD, and protect renal function.

相似文献/References:

[1]朱苗蕊,指导：金智生.糖脂平治疗早期糖尿病肾病60例疗效观察*[J].西部中医药,2013,26(03):74.
　ZHU Miaorui,Director: JIN Zhisheng.Clinical Observation on TangZhiPing in Treating 60 Cases of Early Diabetic Nephropathy[J].Western Journal of Traditional Chinese Medicine,2013,26(09):74.
[2]张鉴明.加味生化汤联合米非司酮、米索前列醇治疗早期妊娠药物流产200例[J].西部中医药,2013,26(04):77.
　ZHANG Jianming.Modified ShengHuaTang Combined with Mifepristone and Misoprostol in Treating 200 Cases of Drug Abortion for Patients in Early Pregnancy[J].Western Journal of Traditional Chinese Medicine,2013,26(09):77.
[3]徐宏.益水生新饮对高血压早期肾损害患者血液流变学及ALB和α1-MG的影响*[J].西部中医药,2013,26(06):4.
　XU Hong.Effects of Y iShui ShengXinY in on Hemorheology, ALB and α1-MG of Hypertensive Patients with Early Renal Damage[J].Western Journal of Traditional Chinese Medicine,2013,26(09):4.
[4]连琯,史晓伟.当归补血汤合金水宝治疗早期糖尿病肾病16例临床观察[J].西部中医药,2013,26(06):68.
　LIAN Guan,SHI Xiaowei.Clinical Observation on DangGui BuXueTang and JinShuiBao in Treating 16 Cases of Early Diabetic Nephropathy[J].Western Journal of Traditional Chinese Medicine,2013,26(09):68.
[5]马天寿.血塞通联合西药治疗糖尿病肾病80例[J].西部中医药,2013,26(08):96.
　MA Tianshou.XueSaiTong Injection and Western Medicine in Treating 80 Cases of Diabetic Nephropathy[J].Western Journal of Traditional Chinese Medicine,2013,26(09):96.
[6]王学琦,李丰华,张荣华,等.温肾汤治疗早期糖尿病肾病80例[J].西部中医药,2013,26(09):62.
　WANG Xueqi,LI Fenghua,ZHANG Ronghua,et al.WenShenTang for 80 Cases of Early Diabetic Nephropathy[J].Western Journal of Traditional Chinese Medicine,2013,26(09):62.
[7]梁彩霞.胃肠道术后早期肠内营养的观察分析[J].西部中医药,2013,26(09):131.
　LIANG Caixia.Analysis and Observation on Early Enteral Nutrition Applied to the Patients with Gastrointestinal Surgery[J].Western Journal of Traditional Chinese Medicine,2013,26(09):131.
[8]任芳,徐厚谦△.黄芪注射液治疗糖尿病肾病随机对照试验报告质量评价[J].西部中医药,2013,26(12):1.
　REN Fang,XU Houqian.Quality Evaluation of the Report for Randomized Controlled Trials of HuangQi Injection in Treating Diabetic Nephropathy[J].Western Journal of Traditional Chinese Medicine,2013,26(09):1.
[9]杨华,曾娟花.血清TNF与2型糖尿病肾病及其中医证型关系的临床研究[J].西部中医药,2014,27(01):11.
　YANG Hua,ZENG Juanhua.Clinical Study on the Relationship between Serum TNF and Type 2 Diabetic Nephropathy[J].Western Journal of Traditional Chinese Medicine,2014,27(09):11.
[10]任芳,徐厚谦△.黄芪注射液治疗糖尿病肾病有效性及安全性的系统评价[J].西部中医药,2014,27(01):77.
　REN Fang,XU Houqian.Systematic Review of the Effectiveness and Safety of HuangQi Injection in Treating Diabetic Nephropathy[J].Western Journal of Traditional Chinese Medicine,2014,27(09):77.
[11]林晓芬,黄燕璇.益肾汤联合厄贝沙坦及胰激肽原酶治疗早期糖尿病肾病的疗效观察[J].西部中医药,2013,26(07):68.
　LIN Xiaofen,HUANG Yanxuan.Clinical Observation on YiShenTang Combined with Irbesartan and Pancreatic Kininogenase in the Treatment for Early Diabetic Nephropathy[J].Western Journal of Traditional Chinese Medicine,2013,26(09):68.
[12]王永军,石良静,等.益气养阴通络方对早期糖尿病肾病患者炎症因子及肾功能的影响[J].西部中医药,2020,33(05):82.[doi:10.12174/j.issn.1004-6852.2020.05.23]
　WANG Yongjun,SHI Liangjing,FAN Zhengchao,et al.Influence of Qi-invigorating Yin-nourishing Collateral-dredging Prescription on Inflammatory Factors and Renal Function of the Patients with Early Diabetic Nephropathy[J].Western Journal of Traditional Chinese Medicine,2020,33(09):82.[doi:10.12174/j.issn.1004-6852.2020.05.23]
[13]朱祎,李晓华.叶氏益肾降糖方治疗早期糖尿病肾病疗效观察[J].西部中医药,2020,33(07):118.[doi:10.12174/j.issn.1004-6852.2020.07.31]
　ZHU Yi,LI Xiaohua.Clinical Effects of Ye′s Yishen Jiangtang Prescription in Treating Early Diabetic Nephropathy[J].Western Journal of Traditional Chinese Medicine,2020,33(09):118.[doi:10.12174/j.issn.1004-6852.2020.07.31]
[14]任秋月,常柏.水陆二仙丹合抵挡汤加减治疗早期糖尿病肾病的前瞻性研究[J].西部中医药,2021,34(07):9.[doi:10.12174/j.issn.2096-9600.2021.07.03]
　REN Qiuyue,CHANG Bai.Prospective Study on Modified Shuilu Erxian Pills and Didang Decoction in the Treatment of Early Diabetic Nephropathy[J].Western Journal of Traditional Chinese Medicine,2021,34(09):9.[doi:10.12174/j.issn.2096-9600.2021.07.03]

备注/Memo

备注/Memo:
吕翠岩（1974—），女，博士学位，硕士研究生导师，副教授，主任医师。研究方向：中医药防治肾病、糖尿病及并发症的临床及作用机制研究。国家重大新药创制项目（2012ZX09102201-001）；北京中医药大学创新团队项目（2011-CXTD-19）；教育部中医养生学重点实验室资助项目；北京市中医养生学重点实验室资助项目；首都医科大学科研培育基金（校基金）（PYZ2017140）。
更新日期/Last Update: 2021-09-15